Inventage Lab is a leading brand in the field of microfluidics-based drug delivery systems. With a strong focus on technological innovation, the company combines their original technology, Laminar-FLUIDigm™, with drug delivery to develop groundbreaking pharmaceuticals. Their platform technology integrates microfluidics into pharmaceutical research and development, enabling the development and production of long-acting injectables based on microspheres and lipid nanoparticles.

Inventage Lab stands out in the industry with their unique-in-class products and joint development projects. They offer a range of innovative solutions, including a one-month and three-month sustained-release treatment for male pattern baldness, a one-month sustained-release treatment for dementia, and the re-discovery of drugs for rheumatoid arthritis, multiple sclerosis, and HIV treatment. The company continuously strives to advance human life and health by leveraging their expertise and passion for groundbreaking pharmaceuticals.

For more information about their pipeline, research, and development, and media updates, visit their website or get in touch with their dedicated professionals. Inventage Lab is committed to the advancement of healthcare and improving the quality of human life through their cutting-edge drug delivery systems